Cubist Systematic Strategies, LLC - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 97 filers reported holding IMMUNOVANT INC in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$7,070,939
+369.5%
184,187
+132.0%
0.05%
+420.0%
Q2 2023$1,505,997
-36.9%
79,388
-48.4%
0.01%
-33.3%
Q1 2023$2,385,726
+57.3%
153,819
+80.0%
0.02%
+66.7%
Q4 2022$1,516,525
+689.9%
85,438
+148.1%
0.01%
+800.0%
Q3 2022$192,000
+74.5%
34,431
+22.2%
0.00%0.0%
Q2 2022$110,000
-50.0%
28,167
-29.5%
0.00%
-50.0%
Q1 2022$220,000
-62.0%
39,932
-41.2%
0.00%
-66.7%
Q4 2021$579,000
-46.1%
67,944
-45.0%
0.01%
-57.1%
Q3 2021$1,074,000
+95.6%
123,602
+138.0%
0.01%
+133.3%
Q2 2021$549,000
-74.2%
51,933
-60.9%
0.01%
-77.8%
Q1 2021$2,129,000
+327.5%
132,741
+1132.2%
0.03%
+285.7%
Q4 2020$498,000
-42.8%
10,773
-56.4%
0.01%
-46.2%
Q3 2020$870,000
+698.2%
24,729
+450.9%
0.01%
+550.0%
Q2 2020$109,000
+2080.0%
4,489
+1224.2%
0.00%
Q1 2020$5,0003390.00%
Other shareholders
IMMUNOVANT INC shareholders Q2 2022
NameSharesValueWeighting ↓
Alpine Global Management, LLC 4,448,017$17,347,0004.39%
Deep Track Capital, LP 9,455,000$36,875,0002.42%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 233$60,000,0000.63%
Octagon Capital Advisors LP 579,061$2,258,0000.60%
Eventide Asset Management 5,372,512$20,953,0000.45%
WITTENBERG INVESTMENT MANAGEMENT, INC. 174,000$679,0000.29%
Frazier Life Sciences Management, L.P. 585,759$2,284,0000.22%
BCK CAPITAL MANAGEMENT LP 54,293$212,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 777,590$3,033,0000.12%
Bridgefront Capital, LLC 15,649$61,0000.07%
View complete list of IMMUNOVANT INC shareholders